Ciprofloxacin Hydrochloride; Hydrocortisone Patent Expiration
Ciprofloxacin Hydrochloride; Hydrocortisone is Used for treating otitis. It was first introduced by Sandoz Inc
Ciprofloxacin Hydrochloride; Hydrocortisone Patents
Given below is the list of patents protecting Ciprofloxacin Hydrochloride; Hydrocortisone, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Cipro Hc | US5843930 | Method of treating otitis with ciprofloxacin-hydrocortisone suspension |
Jun 06, 2015
(Expired) | Sandoz |
Cipro Hc | US5965549 | Ciprofloxacin-hydrocortisone suspension |
Jun 06, 2015
(Expired) | Sandoz |
Ciprofloxacin Hydrochloride; Hydrocortisone's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List